Aqueous Inflammation and Ischemia-Related Biomarkers in Neovascular Glaucoma with Stable Iris Neovascularization

References

• Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26(5):470–85. doi:10.1016/j.preteyeres.2007.06.001.
   PubMed Web of Science ®Google Scholar
• Rodrigues GB, Abe RY, Zangalli C, Sodre SL, Donini FA, Costa DC, Leite A, Felix JP, Torigoe M, Diniz-Filho A, et al. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016;2:26. eCollection 2016. doi:10.1186/s40942-016-0051-x.
   Google Scholar
• Simha A, Braganza A, Abraham L, Samuel P, Lindsley K. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev. 2013;10:CD007920.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liang Y, Zhou P, Wu H, Hou X, Ren Z, Li X, Zhao M. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. BMC Ophthalmol. 2016;16(1):150. doi:10.1186/s12886-016-0327-9.
   PubMed Web of Science ®Google Scholar
• Ha JY, Lee TH, Sung MS, Park SW. Efficacy and safety of intracameral bevacizumab for treatment of neovascularglaucoma. Korean J Ophthalmol. 2017;31(6):538–47. doi:10.3341/kjo.2017.0017.
   PubMedGoogle Scholar
• Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascularglaucoma. Am J Ophthalmol. 2006;142(6):1054–56. doi:10.1016/j.ajo.2006.06.066.
   PubMed Web of Science ®Google Scholar
• Higashide T, Ohkubo S, Sugiyama K. Long-term outcomes and prognostic factors of trabeculectomy following intraocular bevacizumab injection for neovascular glaucoma. PLoS One. 2015;10(8):e0135766. doi:10.1371/journal.pone.0135766.
   PubMed Web of Science ®Google Scholar
• Olmos LC, Sayed MS, Moraczewski AL, Gedde SJ, Rosenfeld PJ, Shi W, Feuer WJ, Lee RK. Long-term outcomes of neovascular glaucoma treated with and without intravitrealbevacizumab. Eye (Lond). 2016;30(3):463–72. doi:10.1038/eye.2015.259.
   PubMed Web of Science ®Google Scholar
• The Early Treatment Diabetic Retinopathy Study Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: early treatment diabetic retinopathy study report number 3. Int Ophthalmol Clin. 1987;27:254–64. doi:10.1097/00004397-198702740-00005.
   PubMedGoogle Scholar
• Kovacs K, Marra KV, Yu G, Wagley S, Ma J, Teague GC, Nandakumar N, Lashkari K, Arroyo JG. Angiogenic and inflammatory vitreous biomarkers associated with increasing levels of retinal ischemia. Invest Ophthalmol Vis Sci. 2015;56(11):6523–30. doi:10.1167/iovs.15-16793.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhou M, Wang W, Wu H, Yu X, Huang W, Gao X, Wang J, Li X, Du S, et al. Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes. ActaOphthalmol. 2015;93:e556–60.
   PubMed Web of Science ®Google Scholar
• Cantor LB, Mantravadi A, WuDunn D, Swamynathan K, Cortes A. Morphologic classification of filtering blebs after glaucoma filtration surgery: the Indiana bleb appearance grading scale. J Glaucoma. 2003;12:266–71. doi:10.1097/00061198-200306000-00015.
   PubMed Web of Science ®Google Scholar
• Kim M, Lee C, Payne R, Yue BYJT, Chang JH, Ying H. Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: a review. Surv Ophthalmol. 2015;60(6):524–35. doi:10.1016/j.survophthal.2015.04.003.
   Google Scholar
• Lopilly Park HY, Kim JH, Ahn MD, Park CK. Level of vascular endothelial growth factor in tenon tissue and results of glaucoma surgery. Arch Ophthalmol. 2012;130(6):685–89. doi:10.1001/archophthalmol.2011.2799.
   PubMedGoogle Scholar
• Lee TH, Avraham H, Lee SH, Avraham S. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem. 2002;277:10445–51.
   PubMed Web of Science ®Google Scholar
• Petrovic MG, Korosec P, Kosnik M, Hawlina M. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2007;143(1):175–76. doi:10.1016/j.ajo.2006.07.032.
   PubMed Web of Science ®Google Scholar
• Chono I, Miyazaki D, Miyake H, Komatsu N, Ehara F, Nagase D, Kawamoto Y, Shimizu Y, Ideta R, Inoue Y. High interleukin-8 level in aqueous humor is associated with poor prognosis in eyes with open angle glaucoma and neovascular glaucoma. Sci Rep. 2018;8(1):14533. doi:10.1038/s41598-018-32725-3.
   PubMed Web of Science ®Google Scholar
• Shirley DSL, Leow SN, Munisvaradass R, Koh EH, Bastion ML, Then KY, Kumar S, Mok PL. Revisiting the role of erythropoietin for treatment of ocular disorders. Eye (Lond). 2016;30(10):1293–309. doi:10.1038/eye.2016.94.
   PubMed Web of Science ®Google Scholar
• Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck K-H. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res. 2002;64:326–33. doi:10.1006/mvre.2002.2426.
   PubMed Web of Science ®Google Scholar
• Pagonopoulou O, Efthimiadou A, Lambropoulou M, Papadopoulos N, Nikolettos NK. Erythropoietin and growth factors exhibit differential angiogenic potential in mouse heart. In Vivo. 2008;22:587–92.
   PubMed Web of Science ®Google Scholar
• Kertesz N, Wu J, Chen TH, Sucov HM, Wu H. The role of erythropoietin in regulating angiogenesis. Dev Biol. 2004;276(1):101–10. doi:10.1016/j.ydbio.2004.08.025.
   PubMed Web of Science ®Google Scholar
• Beirão JM, Moreira LM, Oliveira JC, Menéres MJ, Pessoa BB, Matos ME, Costa PP, Torres PA, Beirão IB. Aqueous humor erythropoietin levels in open-angle glaucoma patients with and without TTR V30M familial amyloid polyneuropathy. Mol Vis. 2014;20:970–76.
   PubMed Web of Science ®Google Scholar
• Nassiri N, Majdi M, Mehrjardi HZ, Shakiba Y, Haghnegahdar M, Heidari AB, Djalilian AR, Mirahmadian M. Erythropoietin levels in aqueous humor of patients with glaucoma. Mol Vis. 2012;18:1991–95.
   PubMed Web of Science ®Google Scholar
• Zhou M, Chen S, Wang W, Huang W, Cheng B, Ding X, Zhang X. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab. Invest Ophthalmol Vis Sci. 2013;54(6):3874–79. doi:10.1167/iovs.12-11507.
   PubMed Web of Science ®Google Scholar
• Inomata Y, Hirata A, Takahashi E, Kawaji T, Fukushima M, Tanihara H. Elevated erythropoietin in vitreous with ischemic retinal diseases. Neuroreport. 2004;15:877–79. doi:10.1097/00001756-200404090-00029.
   PubMed Web of Science ®Google Scholar
• Katsura Y, Okano T, Matsuno K, Osako M, Kure M, Watanabe T, Iwaki Y, Noritake M, Kosano H, Nishigori H, et al. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care. 2005;28:2252–54. doi:10.2337/diacare.28.9.2252.
   PubMed Web of Science ®Google Scholar
• Kase S, Saito W, Ohgami K, Yoshida K, Furudate N, Saito A, Yokoi M, Kase M, Ohno S. Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy. Br J Ophthalmol. 2007;91(10):1376–78. doi:10.1136/bjo.2007.119404.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Missotten L, Geboes K. Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascularepiretinal membranes. Br J Ophthalmol. 2007;91(6):822–26. doi:10.1136/bjo.2006.109876.
   PubMed Web of Science ®Google Scholar
• Ergorul C, Ray A, Huang W, Wang DY, Ben Y, Cantuti-Castelvetri I, Grosskreutz CL. Hypoxia inducible factor-1α (HIF-1α) and some HIF-1 target genes are elevated in experimental glaucoma. J Mol Neurosci. 2010;42:183–91.
   PubMed Web of Science ®Google Scholar
• Huang W, Gao X, Chen S, Li X, Zhang X, Zhang X. Vascular endothelial growth factor is increased in aqueous humor of acute primary angle-closure eyes. J Glaucoma. 2016;25(7):e647–51. doi:10.1097/IJG.0000000000000242.
   PubMed Web of Science ®Google Scholar
• Huang W, Chen S, Gao X, Yang M, Zhang J, Li X, Wang W, Zhou M, Zhang X, Zhang X. Inflammation-related cytokines of aqueous humor in acute primary angle-closure eyes. Invest Ophthalmol Vis Sci. 2014;55(2):1088–94. doi:10.1167/iovs.13-13591.
   PubMed Web of Science ®Google Scholar
• Duvesh R, Puthuran G, Srinivasan K, Rengaraj V, Krishnadas SR, Rajendrababu S, Balakrishnan V, Ramulu P, Sundaresan P. Multiplex cytokine analysis of aqueous humor from the patients with chronic primary angle closure glaucoma. Curr Eye Res. 2017;42(12):1608–13. doi:10.1080/02713683.2017.1362003.
   PubMed Web of Science ®Google Scholar
• Freedman J, Iserovich P. Pro-inflammatory cytokines in glaucomatous aqueous and encysted Molteno implant blebs and their relationship to pressure. Invest Ophthalmol Vis Sci. 2013;54(7):4851–55. doi:10.1167/iovs.13-12274.
   PubMed Web of Science ®Google Scholar
• Prendes MA, Harris A, Wirostko BM, Gerber AL, Siesky B. The role of transforming growth factor β in glaucoma and the therapeutic implications. Br J Ophthalmol. 2013;97(6):680–86. doi:10.1136/bjophthalmol-2011-301132.
   PubMed Web of Science ®Google Scholar
• Shobayashi K, Inoue T, Kawai M, Iwao K, Ohira S, Kojima S, Kuroda U, Nakashima K, Tanihara H. Postoperative changes in aqueous monocyte chemotactic protein-1 levels and bleb morphology after trabeculectomy vs. Ex-PRESS shunt surgery. PLoS One. 2015;10(10):e0139751. doi:10.1371/journal.pone.0139751.
   PubMed Web of Science ®Google Scholar
• Kubota T, Aoki R, Harada Y, Tou N, Kohno Y, Tawara A, Satoh H, Shimajiri S. Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab. Br J Ophthalmol. 2009;93(4):557–58. doi:10.1136/bjo.2008.148148.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Kobayashi Y, Nakao S, Sassa Y, Hisatomi T, Ikeda Y, Oshima Y, Kono T, Ishibashi T, Sonoda KH. Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy. Clin Ophthalmol. 2017;11:1697–705. doi:10.2147/OPTH.S141821.
   PubMed Web of Science ®Google Scholar
• Peters S, Julien S, Heiduschka P, Grisanti S, Ziemssen F, Adler M, Schraermeyer U, Bartz-Schmidt KU. Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells. Br J Ophthalmol. 2007;91(6):827–31. doi:10.1136/bjo.2006.109702.
   PubMed Web of Science ®Google Scholar
• Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosisiridis from a single bevacizumab (Avastin) injection. Retina. 2006;26(3):354–56. doi:10.1097/00006982-200603000-00017.
   PubMed Web of Science ®Google Scholar
• Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2006;142(1):155–58. doi:10.1016/j.ajo.2006.02.015.
   PubMed Web of Science ®Google Scholar
• Ohira S, Inoue T, Shobayashi K, Iwao K, Fukushima M, Tanihara H. Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection. Invest Ophthalmol Vis Sci. 2015;56(6):3541–48. doi:10.1167/iovs.14-15918.
   PubMed Web of Science ®Google Scholar
• Chalam KV, Brar VS, Murthy RK. Human ciliary epithelium as a source of synthesis and secretion of vascular endothelial growth factor in neovascular glaucoma. JAMA Ophthalmol. 2014;132(11):1350–54. doi:10.1001/jamaophthalmol.2014.2356.
   PubMed Web of Science ®Google Scholar